About this trial
In France, the treatment of chronic insomnia relies mainly on hypnotic drugs in routine care, despite the high level of iatrogenicity. Cognitive-behavioral therapy (CBT) is recommended by the HAS as a non-pharmaceutical first-line therapy for chronic insomnia. Despite evidence of their efficacy in chronic insomnia, these therapies remain underdeveloped in France (few practitioners, time-consuming for the patient). Hypnotherapy is another non-drug intervention suitable for routine outpatient care. Among the hypnosis methods practiced in France, E2R (Emotion, Regression, Repair) is a hypnotherapy method used in general practice, particularly for chronic insomnia. To date, no clinical trials have been carried out to demonstrate its effectiveness in this pathology.
The HypERR study is a multicenter, randomized, open-label study designed to evaluate the efficacy of a hypotherapy method called E2R in the management of chronic insomnia, by comparing it with standard care (without hypnosis).
Eligibility criteria
Qualifiers
Patient aged 18 or over,
Patient willing to undergo hypnotherapy for 4 sessions of 30 min over 6 weeks,
Patient whose treating physician is the investigator,
Patient able to give free, informed, written consent,
Disqualifiers
Patients receiving or having received one or more hypnotherapy sessions (for any reason) in the last 5 years prior to inclusion,
Patient participating in another study involving the treatment of insomnia or another pathology having an impact on sleep disorders,
Patient unable to complete a self-administered questionnaire,
Patients with poor or no understanding of the French language,
Trial design
Treatments tested in this trial
- "Standard care" control group (without hypnosis)
- Experimental group: "E2R hypnosis"
Treatment groups
Sponsors and collaborators
Rennes University Hospital
Lead sponsor
University of Rennes
Collaborator